ON-DEMAND WEBCAST

N-nitrosamine Impurities in Drugs

Enter your details below to watch the webcast.

First Name *

Last Name *

Job Title *

Company *

Email *

Country *

Opt-in to receive periodic industry insights, event invitations, product updates, and other information from Instem.

Comments

Introducing the EMA-Mutamind Project

This presentation will deep dive into some of the key concerns surrounding N-nitrosamine impurities in drugs, whilst sharing a QSAR project study and design tool to investigate the metabolic activation, DNA adduct formation and DNA repair mechanisms to distinguish NA classes with distinct mutagenic potency.

Dr. Kevin Cross

VP of Product Development, Instem